Zheng, Zhi Nuo, et al. “Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates”. World Journal of Oncology, vol. 17, no. 2, Jan. 2026, pp. 129-42, https://doi.org/10.14740/wjon2718.